Literature DB >> 9188742

Structural definition of the C5a C terminus by two-dimensional nuclear magnetic resonance spectroscopy.

X Zhang1, W Boyar, M J Toth, L Wennogle, N C Gonnella.   

Abstract

The serum glycoprotein C5a, which is derived from the proteolytic cleavage of complement protein C5, has been implicated in the pathogenesis of a number of inflammatory and allergic conditions. Because C5a induces an inflammatory response upon binding to a specific receptor, structural and mutagenesis studies were carried out to gain a better understanding of this binding interaction. These studies led to the first structural definition of the C terminus of recombinant human (rh)-C5a, determined by two-dimensional nuclear magnetic resonance (NMR) spectroscopy. Our results show that the C terminus adopts an alpha-helical conformation spanning residues 69 to 74, while the core domain exists as an antiparallel alpha-helical bundle. This C-terminal helix is connected to the core by a short loop that orients Arg 74 adjacent to Arg 62. Point mutation analysis had already revealed that residues 62 and 74 significantly contribute to agonist activity and receptor binding. Correlation of the C5a tertiary structure with mutational analyses clarifies the significance of the functional and binding properties of Arg 62 and suggests that both Arg 62 and Arg 74 interact at the same binding site on the receptor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9188742     DOI: 10.1002/(sici)1097-0134(199706)28:2<261::aid-prot13>3.0.co;2-g

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  21 in total

1.  Structure of the streptococcal cell wall C5a peptidase.

Authors:  C Kent Brown; Zu-Yi Gu; Yury V Matsuka; Sai S Purushothaman; Laurie A Winter; P Patrick Cleary; Stephen B Olmsted; Douglas H Ohlendorf; Cathleen A Earhart
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

Review 2.  Complement evasion by human pathogens.

Authors:  John D Lambris; Daniel Ricklin; Brian V Geisbrecht
Journal:  Nat Rev Microbiol       Date:  2008-02       Impact factor: 60.633

Review 3.  Overview of protein structural and functional folds.

Authors:  Peter D Sun; Christine E Foster; Jeffrey C Boyington
Journal:  Curr Protoc Protein Sci       Date:  2004-05

Review 4.  C4a: An Anaphylatoxin in Name Only.

Authors:  Scott R Barnum
Journal:  J Innate Immun       Date:  2015-02-06       Impact factor: 7.349

5.  Identification of receptor-binding sites of monocyte chemotactic S19 ribosomal protein dimer.

Authors:  Y Shibuya; M Shiokawa; H Nishiura; T Nishimura; N Nishino; H Okabe; K Takagi; T Yamamoto
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

6.  Switch moiety in agonist/antagonist dual effect of S19 ribosomal protein dimer on leukocyte chemotactic C5a receptor.

Authors:  Arjun Shrestha; Megumi Shiokawa; Takumasa Nishimura; Hiroshi Nishiura; Yuji Tanaka; Norikazu Nishino; Yoko Shibuya; Tetsuro Yamamoto
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

7.  Structure of the tyrosine-sulfated C5a receptor N terminus in complex with chemotaxis inhibitory protein of Staphylococcus aureus.

Authors:  Johannes H Ippel; Carla J C de Haas; Anton Bunschoten; Jos A G van Strijp; John A W Kruijtzer; Rob M J Liskamp; Johan Kemmink
Journal:  J Biol Chem       Date:  2009-02-27       Impact factor: 5.157

8.  Human C3a and C3a desArg anaphylatoxins have conserved structures, in contrast to C5a and C5a desArg.

Authors:  Goran Bajic; Laure Yatime; Andreas Klos; Gregers Rom Andersen
Journal:  Protein Sci       Date:  2012-12-16       Impact factor: 6.725

9.  Targeted Amino Acid Substitution Overcomes Scale-Up Challenges with the Human C5a-Derived Decapeptide Immunostimulant EP67.

Authors:  Abdulraman M Alshammari; D David Smith; Jake Parriott; Jason P Stewart; Stephen M Curran; Russell J McCulloh; Peter A Barry; Smita S Iyer; Nicholas Palermo; Joy A Phillips; Yuxiang Dong; Donald R Ronning; Jonathan L Vennerstrom; Sam D Sanderson; Joseph A Vetro
Journal:  ACS Infect Dis       Date:  2020-04-13       Impact factor: 5.084

10.  The structure of OMCI, a novel lipocalin inhibitor of the complement system.

Authors:  Pietro Roversi; Olga Lissina; Steven Johnson; Nurfilza Ahmat; Guido C Paesen; Kerstin Ploss; Wilhelm Boland; Miles A Nunn; Susan M Lea
Journal:  J Mol Biol       Date:  2007-03-30       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.